Next, we determined whether the deletion of Prdx5 was related to the expression and activity of NCC, which has been shown to cause hypertension, and whether the efficacy of Prdx5 was dependent on the WNK-SPAK/OSR1 pathway, the master activator of NCCs. This evidence concerns the gene SLC12A3 and hypertensive disorder.